Drugdiscovery >> Pharmaceutical Companies >> News
4981
Views
Sunovion Pharma and Afraxis join forces in CNS drug discovery - drugdiscovery.com
Sunovion Pharma and Afraxis join forces in CNS drug discovery - drugdiscovery.com


The companies have signed a collaboration agreement to boost Sunovion’s preclinical central nervous system (CNS) drug discovery process by using a unique enhanced spine platform developed by Afraxis.
Read More >>


Tags: Sunovion, Afraxis, partnership,colaboration, CNS drugs - August 16, 2013
Related Articles
1476
Views
AstraZeneca CFO to join BG AstraZeneca CFO to join BG
Simon Lowth, chief financial officer at AstraZeneca, is leaving the pharmaceutical company to take on the same role at oil and gas group BG. Read More >>

Tags: AstraZeneca,Simon Lowth

1749
Views
AstraZeneca suffers 17% fall, but still stands AstraZeneca suffers 17% fall, but still stands
Astra zeneca suffered 17% loss on stock exchange due to patent loosings of veteran drugs. However, the company is still positive about its future and hopes to regain what it has lost. Read More >>

Tags: pharma, pharmaceutical companies, pharma loss, Astra Zeneca, veteran drugs

1109
Views
Prescriptions rising along with  pharma payments Prescriptions rising along with pharma payments
A new study shows that drugmakers do influence in more ways doctors' prescribing habits. Read More >>

Tags: pharma payments, drugmakers, doctors, prescribing habits

1322
Views
Top pharma's innovators Top pharma's innovators
See which pharma companies are on the Forbes' latest list of 100 most innovative companies on the globe. Read More >>

Tags: pharma, companies, drugmakers, biotechs, innovators,innovative, Forbes, list, top

3989
Views
A new leukemia drug id going to be made by Pfizer A new leukemia drug id going to be made by Pfizer
Avalliaon Group and Pfizer work together on developing a new type of pharma. The leukemia drug is in Phase 3 clinical trial now. Read More >>

Tags: Phase , clinical trial, pharma

4895
Views
 The most efficient drug developers in Big Pharma world The most efficient drug developers in Big Pharma world
Matthew Herper from Forbes investigates which are the most efficient drug developers in biopharma. Read More >>

Tags: drug developers, best, most efficent, biopharma

1325
Views
Fujifilm Pharma and Boston Strategics are partneres Fujifilm Pharma and Boston Strategics are partneres
Preclinical and early clinicaldevelopment of oncology drugs is going to be easier after Fujifilm Pharma and Boston Strategic signed the contribution. The contract opens an opportunity for a world-wide Read More >>

Tags: opportunity, world-sire, research, Fujifilm Pharma, Boston Strategics

3330
Views
State of the art of the Pharmaceutical Industry State of the art of the Pharmaceutical Industry
In the United States alone, more than $100 billion is spent annually on pharmaceutical research and development. The pharmaceutical industry has a higher level of expenditures than any other manufactu Read More >>

Tags: drug discovery, pharmaceutical industry, drugs, drug development, clinical trials

3949
Views
Novartis has named the new leaders of Alcon and Sandoz Novartis has named the new leaders of Alcon and Sandoz
These new leaders will set the direction for the next phase of growth for our eye care and generics businesses, two of our core growth engines. Read More >>

Tags: biosimilars, pharmaceutical business, pharma leaders, novartis, alcon, sandoz, drug, drug ceo, Chutes and Ladders, Novartis, Sandoz,

1788
Views
Eli Lilly's lung cancer drug is protected by the court Eli Lilly's lung cancer drug is protected by the court
federal court decided to protect Lilly's experimental cacer drug from its generic version.The drug is going to be protected till 2022. Read More >>

Tags: drug; discovery; development; patent protection; Eli Lilly; Alimta; lung cancer

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013